Cart
sales@molnova.com
Meclofenamic acid
CAS No. 644-62-2
Meclofenamic acid ( Meclofenamate )
Catalog No. M26293 CAS No. 644-62-2
Meclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 659 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMeclofenamic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
-
DescriptionMeclofenamic acid is a non-selective gap-junction blocker and a selective fat mass and obesity-associated (FTO) enzyme inhibitor. Meclofenamic acid has anti-inflammatory activities.
-
SynonymsMeclofenamate
-
PathwayOthers
-
TargetOther Targets
-
RecptorMajor prion protein
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number644-62-2
-
Formula Weight296.2
-
Molecular FormulaC14H11Cl2NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kimata A, et al. New series of antiprion compounds: pyrazolone derivatives have the potent activity of inhibiting protease-resistant prion protein accumulation [published correction appears in J Med Chem. 2008 Mar 13;51(5):1503]. J Med Chem. 2007;50(21):5053-5056.
molnova catalog
related products
-
Compound 35
Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses.Compounds 35 are superior inhibitors of Ebola (Mayinga) and Marburg (Angola) infectious viruses. Compounds 35 have shown good metabolic stability in plasma and liver microsomes (rat and human), and 32 did not inhibit CYP3A4 nor CYP2C9.
-
Antioxidant peptide ...
Antioxidant peptide A is a short peptide, which contains alternative aromatic or sulfur-containing amino acid.
-
Hydroxocobalamin ace...
Hydroxocobalamin acetate is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the treatment of vitamin B12 deficiency including pernicious anemia.?
